Sabby Management’s Vivani Medical VANI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-93,825
Closed -$121K 62
2025
Q2
$121K Sell
93,825
-757,782
-89% -$835K 0.22% 30
2025
Q1
$894K Sell
851,607
-459,832
-35% -$528K 2.63% 11
2024
Q4
$1.52M Sell
1,311,439
-816,603
-38% -$1.03M 1.98% 9
2024
Q3
$2.49M Buy
2,128,042
+1,866
+0.1% +$2.33K 1.34% 6
2024
Q2
$2.68M Sell
2,126,176
-546,842
-20% -$937K 1.8% 6
2024
Q1
$4.95M Buy
+2,673,018
New +$3.94M 2.85% 5
2022
Q1
Sell
-163,991
Closed -$802K 192
2021
Q4
$802K Buy
163,991
+66,667
+69% +$487K 0.12% 90
2021
Q3
$931K Buy
97,324
+39,024
+67% +$439K 0.13% 87
2021
Q2
$864K Sell
58,300
-249,098
-81% -$4.81M 0.12% 90
2021
Q1
$7.61M Buy
+307,398
New +$4.59M 1.48% 11

Other funds holding VANI

Sabby Management's VANI Position: Q3 2025 in Review

Sabby Management sold out of Vivani Medical (VANI) in Q3 2025, closing a stake of 93,825 shares — an estimated $121K sold.

Sabby Management first reported a position in VANI in Q1 2021 and held it in 10 quarters. The position peaked at $7.61M in Q1 2021. 29 funds tracked by Wall St. Rank hold VANI as of Q3 2025.

  • Sabby Management reported no remaining Vivani Medical position as of Q3 2025 after selling out during the quarter.
  • Sabby Management sold 93,825 Vivani Medical shares in Q3 2025, an estimated $121K.
  • Sabby Management first reported a position in Vivani Medical in Q1 2021 and held it in 10 quarters.
  • Sabby Management's Vivani Medical position peaked at $7.61M in Q1 2021.
  • 29 funds tracked by Wall St. Rank held Vivani Medical as of Q3 2025.

Based on Sabby Management's 13F filing for Q3 2025, filed 14 Nov 2025.